BIOSTAGE
Biostage is a pioneering biotechnology company in the emerging field of regenerative medicine. Their goal is to regenerate and restore organ function of the esophagus, trachea, or bronchus damaged by cancer, trauma, infection, or congenital diseases. The company’s novel Cellframe technology is engineered to stimulate the body’s signaling pathways and natural healing process to regenerate and restore organ function. Our Cellframe technology is based on over 20 years of scientific progress in the fields of tissue engineering, cell biology, and material science. Cellframe technology combines the best attributes of a synthetic scaffold with tissue engineering and cell biology to create what may be a revolutionary method of addressing organ damage.
BIOSTAGE
Industry:
Biotechnology Health Care Medical Device
Founded:
2012-05-03
Address:
Holliston, Massachusetts, United States
Country:
United States
Website Url:
http://www.biostage.com
Total Employee:
11+
Status:
Active
Contact:
+117742337300
Email Addresses:
[email protected]
Total Funding:
24.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Font Awesome IPv6 ReCAPTCHA Cloudflare Cloudflare Hosting Cloudflare SSL ReCAPTCHA V2
Similar Organizations
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Connecticut Children’s Medical Center
Connecticut Children’s Medical Center investment in Post-IPO Equity - Biostage
Bin Zhao
Bin Zhao investment in Post-IPO Equity - Biostage
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-08 | Biostage Announces Appointment of New Chief Financial Officer |
| 2022-01-25 | Biostage Announces "Meet the Founder, New Chairman and Interim CEO" Webinar |
| 2021-11-30 | Biostage Hires David Green as Chief Executive Officer |
Official Site Inspections
http://www.biostage.com Semrush global rank: 5.73 M Semrush visits lastest month: 1.46 K
- Host name: 172.67.207.15
- IP address: 172.67.207.15
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Biostage"
Biostage, Inc. Changes Name to Harvard Apparatus Regenerative ...
HOLLISTON, Mass., July 20, 2023 /PRNewswire/ -- Biostage, Inc. (OTCQB: formerly BSTG) announced today it has changed its corporate name back to Harvard Apparatus Regenerative …See details»
Biostage Company Profile - Office Locations, Competitors ... - Craft
Sep 20, 2023 Biostage has 5 employees at their 1 location and $430 k in annual revenue in FY 2024. See insights on Biostage including office locations, competitors, revenue, financials, …See details»
Biostage, Inc. Information - RocketReach
The NAICS codes for Biostage, Inc. are [541, 541713, 5417, 54, 54171]. What is the SIC code for Biostage, Inc.? The SIC codes for Biostage, Inc. are [873, 87]. Top Biostage, Inc. Employees …See details»
Biostage, Inc | Ocean 海外华人企业家联合会
Ocean - Oversea Chines-American Entrepreneur Association, 海外华人企业家联合会, is an officially registered in 1999 as non-political, non-religion and non-profit organization, headquartered in Boston, Massachusetts. The mission of …See details»
Biostage - The Org
Biostage is a bioengineering company that is developing next-generation esophageal implants. The Company's Cellspan technology combines a proprietary, biocompatible scaffold with a …See details»
Biostage - Overview, News & Similar companies | ZoomInfo.com
Jul 19, 2023 Biostage Initiated Study Start-up Activities for Clinical Trial in Severe Esophageal Disease HOLLISTON, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- Biostage, Inc. (OTCQB: …See details»
Inside Scoop on Biostage, a World Leader in …
Oct 30, 2017 Biostage is a clinical-stage company specializing in bioengineered organ implants to treat cancer and other conditions involving the esophagus, bronchus and trachea. In August 2017, Biostage transplanted its esophageal …See details»
Company Biostage, Inc. Nasdaq - MarketScreener.com
Business description: Biostage, Inc. Harvard Apparatus Regenerative Technology, Inc. is a clinical-stage biotechnology company. It uses the patientâ s own stem cells grown on a porous …See details»
Biostage Announces $6 Million Financing to Advance Clinical Trial
HOLLISTON, Mass., April 06, 2023 (GLOBE NEWSWIRE) -- Biostage, Inc (Formerly Known As Harvard Apparatus Regenerative Technology), (OTCQB: BSTG) (“Biostage” or the …See details»
Biostage Announces $6 Million Financing to Advance Clinical
Apr 6, 2023 Biostage has 12 issued U.S. patents, 2 issued in China and 2 orphan-drug designations by the FDA which can provide seven years of market exclusivity in addition to …See details»
Biostage, Inc. Company Profile & Data: stocks, market cap, …
Jan 1, 2023 Biostage, Inc. was founded in 2007 and is headquartered in Holliston, Massachusetts. Top 1-year algo backtest: +327.04% $10,000 in March 2024 would now be …See details»
Biostage, Inc. | LinkedIn
Biostage, Inc. | 2,035 followers on LinkedIn. Biostage is a bioengineering company that is developing next-generation esophageal implants. | Biostage Inc., is a clinical stage …See details»
Harvard Apparatus Regenerative Technology - Crunchbase
Biostage is a biotechnology company developing esophageal implants for patients battling life-threatening conditions. It uses the patient’s stem cells grown on a porous plastic tubular …See details»
Biostage secures $6M to advance clinical trials
Apr 7, 2023 Biostage was trading at $6.15 per share on the OTC Market as of open on April 7. “I am very pleased to welcome our new strategic investors and to thank our existing investors for …See details»
Biostage - VentureRadar
" Biostage is a preclinical biotechnology company focused on tissue engineering and the production of combination products designed to restore function of the GI tract following …See details»
Biostage, Inc. Changes Name to Harvard Apparatus ... - BioSpace
Jul 20, 2023 Name Change is Capstone of Corporate Rebranding Initiative for Regenerative Medicine (www.hregen.com) - Trading Under OTCQB Symbol “HRGN” begins July 20, 2023-. …See details»
Biostage Selects IQVIA to Manage its FDA-Approved Clinical Trial …
Dec 28, 2022 David Green, Biostage's founder, Chair of the Board and interim Chief Executive Officer commented, "We are very pleased to be partnering with IQVIA to perform the clinical …See details»
Biostage Announces Chairman and CEO Transition - PR Newswire
HOLLISTON, Mass., March 1, 2023 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a clinical-stage biotechnology company developing regenerative-medicine …See details»
Biostage Activated Mayo Clinic as The First Site for ... - BioSpace
HOLLISTON, Mass., July 18, 2023 /PRNewswire/ -- Biostage, Inc (Formerly Known As Harvard Apparatus Regenerative Technology) (OTCQB: BSTG) (“Biostage” or the “Company”), a …See details»
Biostage Selects IQVIA to Manage its FDA-Approved Clinical
Dec 28, 2022 Biostage, Inc. announced that it had selected IQVIA, a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences …See details»